123 related articles for article (PubMed ID: 7947288)
1. Late listeriosis after fludarabine plus prednisone treatment.
Girmenia C; Mauro FR; Rahimi S
Br J Haematol; 1994 Jun; 87(2):407-8. PubMed ID: 7947288
[TBL] [Abstract][Full Text] [Related]
2. Listeriosis in patients with chronic lymphocytic leukemia who were treated with fludarabine and prednisone.
Anaissie E; Kontoyiannis DP; Kantarjian H; Elting L; Robertson LE; Keating M
Ann Intern Med; 1992 Sep; 117(6):466-9. PubMed ID: 1354425
[TBL] [Abstract][Full Text] [Related]
3. Infections in patients with chronic lymphocytic leukemia treated with fludarabine.
Anaissie EJ; Kontoyiannis DP; O'Brien S; Kantarjian H; Robertson L; Lerner S; Keating MJ
Ann Intern Med; 1998 Oct; 129(7):559-66. PubMed ID: 9758577
[TBL] [Abstract][Full Text] [Related]
4. Listeriosis after fludarabine treatment for chronic lymphocytic leukemia.
Hequet O; de Jaureguiberry JP; Jaubert D; Gisserot O; Muzellec Y; Brisou P
Hematol Cell Ther; 1997 Apr; 39(2):89-91. PubMed ID: 9168306
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary tuberculosis after fludarabine for chronic lymphocytic leukaemia.
Ghosh K; Sivakumaran M; Murphy P; Chapman CS
Natl Med J India; 1995; 8(6):294-5. PubMed ID: 8520454
[No Abstract] [Full Text] [Related]
6. Fatal legionella pneumonia after fludarabine treatment in chronic lymphocytic leukaemia.
Hendrick A
J Clin Pathol; 2001 May; 54(5):412-3. PubMed ID: 11328847
[No Abstract] [Full Text] [Related]
7. Fludarabine + prednisone +/- alpha-interferon followed or not by alpha-interferon maintenance therapy for previously untreated patients with chronic lymphocytic leukemia: long term results of a randomized study.
Mauro FR; Zinzani P; Zaja F; Gentile M; Vegna ML; Stefoni V; Marin L; Fanin R; Baccarani M; Tura S; Mandelli F
Haematologica; 2003 Dec; 88(12):1348-57. PubMed ID: 14687987
[TBL] [Abstract][Full Text] [Related]
8. Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The French Cooperative Group on CLL.
Johnson S; Smith AG; Löffler H; Osby E; Juliusson G; Emmerich B; Wyld PJ; Hiddemann W
Lancet; 1996 May; 347(9013):1432-8. PubMed ID: 8676625
[TBL] [Abstract][Full Text] [Related]
9. Cryptococcal meningitis following fludarabine treatment for chronic lymphocytic leukemia.
Leenders A; Sonneveld P; de Marie S
Eur J Clin Microbiol Infect Dis; 1995 Sep; 14(9):826-8. PubMed ID: 8536738
[No Abstract] [Full Text] [Related]
10. Fludarabine and prednisone in pretreated and refractory B-chronic lymphocytic leukemia (B-CLL) in advanced stages.
De Rossi G; Mauro FR; Caruso R; Monarca B; Mandelli F
Haematologica; 1993; 78(3):167-71. PubMed ID: 8375746
[TBL] [Abstract][Full Text] [Related]
11. Acute myeloid leukemia and myelodysplasia in patients with chronic lymphocytic leukemia receiving fludarabine as initial therapy.
Coso D; Costello R; Cohen-Valensi R; Sainty D; Nezri M; Gastaut JA; Bouabdallah R
Ann Oncol; 1999 Mar; 10(3):362-3. PubMed ID: 10355587
[No Abstract] [Full Text] [Related]
12. Listerial brain abscess in a patient with chronic lymphocytic leukemia treated with fludarabine.
Cleveland KO; Gelfand MS
Clin Infect Dis; 1993 Oct; 17(4):816-7. PubMed ID: 8268374
[No Abstract] [Full Text] [Related]
13. Cerebral toxoplasmosis in a patient with chronic lymphocytic leukaemia treated with fludarabine.
Bacchu S; Fegan C; Neal J
Br J Haematol; 2007 Nov; 139(3):349. PubMed ID: 17784883
[No Abstract] [Full Text] [Related]
14. [Whipple's disease as a complication of chronic lymphocytic leukemia treated with fludarabine].
Kuliszkiewicz-Janus M; Małecki R; Kuliczkowski K; Jeleń M
Pol Arch Med Wewn; 2002 Sep; 108(3):887-91. PubMed ID: 12600186
[TBL] [Abstract][Full Text] [Related]
15. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.
Rai KR; Peterson BL; Appelbaum FR; Kolitz J; Elias L; Shepherd L; Hines J; Threatte GA; Larson RA; Cheson BD; Schiffer CA
N Engl J Med; 2000 Dec; 343(24):1750-7. PubMed ID: 11114313
[TBL] [Abstract][Full Text] [Related]
16. Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic leukemia.
O'Brien S; Moore JO; Boyd TE; Larratt LM; Skotnicki A; Koziner B; Chanan-Khan AA; Seymour JF; Bociek RG; Pavletic S; Rai KR
J Clin Oncol; 2007 Mar; 25(9):1114-20. PubMed ID: 17296974
[TBL] [Abstract][Full Text] [Related]
17. Early cryptococcal meningitis following treatment with rituximab, fludarabine and cyclophosphamide in a patient with chronic lymphocytic leukemia.
Marchand T; Revest M; Tattevin P; Chevrier S; Poullot E; Lamy T; Houot R
Leuk Lymphoma; 2013 Mar; 54(3):643-5. PubMed ID: 22924391
[No Abstract] [Full Text] [Related]
18. Fludarabine as second-line therapy for B cell chronic lymphocytic leukaemia: a technology assessment.
Hyde C; Wake B; Bryan S; Barton P; Fry-Smith A; Davenport C; Song F
Health Technol Assess; 2002; 6(2):1-89. PubMed ID: 12022937
[No Abstract] [Full Text] [Related]
19. Haemophagocytic lymphohistiocytosis following fludarabine/cyclophosphamide chemotherapy for chronic lymphocytic leukaemia.
Jayakody Arachchillage D; Hurst E; Carey P; Moses S; O'Brien SG; Menne T; Keenan F; Wallis JP
Br J Haematol; 2014 Jul; 166(1):142-5. PubMed ID: 24628491
[No Abstract] [Full Text] [Related]
20. The immunosuppression and potential for EBV reactivation of fludarabine combined with cyclophosphamide and dexamethasone in patients with lymphoproliferative disorders.
Lazzarino M; Orlandi E; Baldanti F; Furione M; Pagnucco G; Astori C; Arcaini L; Viglio A; Paulli M; Gerna G; Bernasconi C
Br J Haematol; 1999 Dec; 107(4):877-82. PubMed ID: 10606897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
